ClinicalTrials.gov
public full text
Public Domain
Evaluation of Heparin Rebound in Cardiac Surgery
Recent work has shown that heparin rebound is common after cardiac surgery. The exact doze of protamine required to neutralize heparin at the end of CPB is unknown. Besides, the precise doze of protamine to treat heparin rebound is also unknown. It is also unknown if precise titration of protamine perioperatively in cardiac surgery can influence transfusion requirements after cardiac surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Heparin and the Reduction of Thrombosis (HART) Trial#874232
- Value of Early Postoperative Peptide-based Formula in Critically Ill Obstetrics on Recovery Enhancement#979886
- Letter to the editors: "Thromboelastography to monitor anticoagulation in ICU patients receiving a continuous infusion of unfractionated heparin"#254359
- Acute Normovolemic Hemodilution on Serum-creatinine Concentration in Cardiac Surgery#868390
- Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity#966392
Record · ID 1407222
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive